Key result
Atp1a3-G947R mutant mice exhibit severe motor impairments and prominent seizures resembling AHC-related epilepsy.
Why the study?
Detailed investigations of seizure phenotypes were limited in previously reported mouse models of ATP1A3 variants causing alternating hemiplegia of childhood (AHC).
A novel mouse model expressing the ATP1A3 p.G947R variant replicates key features of alternating hemiplegia of childhood, including severe motor impairments and co-morbid epilepsy, providing an in vivo platform for future research.
Mouse models of ATP1A3 variants may advance AHC epilepsy research; leaves open clinical translation.
Pathogenic variants in ATP1A3 encoding the neuronal Na/K-ATPase cause a spectrum of neurodevelopmental disorders including alternating hemiplegia of childhood (AHC). Three recurrent ATP1A3 variants are associated with approximately half of known AHC cases and mouse models of two of these variants (p.D801N, p.E815K) replicated key features of the human disorder, which include paroxysmal hemiplegia, dystonia and seizures. Epilepsy occurs in 40–50 % of individuals affected with AHC, but detailed investigations of seizure phenotypes were limited in the previously reported mouse models. Using gene editing, we generated a novel AHC mouse expressing the third most recurrent ATP1A3 variant (p.G947R) to model neurological phenotypes of the disorder. Heterozygous Atp1a3 -G947R ( Atp1a3 G947R ) mice on a pure C57BL/6J background were born at a significantly lower frequency than wildtype (WT) littermates, but in vitro fertilization or outcrossing to a different strain (C3HeB/FeJ) generated offspring at near-Mendelian genotype ratios, suggesting a defect in reproductive fitness rather than embryonic lethality. Heterozygous mutant mice were noticeably smaller and exhibited premature lethality, hyperactivity, anxiety-like behaviors, severe motor dysfunction including low grip strength, impaired coordination with abnormal gait and balance, reduced REM sleep, and cooling-induced hemiplegia and dystonia. We also observed a prominent seizure phenotype with lower thresholds to chemically (flurothyl, kainic acid) and electrically induced seizures, post-handling seizures, sudden death following seizures, and abnormal EEG activity. Together, our findings support face validity of a novel AHC mouse model with quantifiable traits including co-morbid epilepsy that will be useful as an in vivo platform for investigating pathophysiology and testing new therapeutic strategies for this rare neurodevelopmental disorder. • Mice heterozygous for a recurrent ATP1A3 variant exhibit cardinal features of alternating hemiplegia of childhood (AHC) • Heterozygous Atp1a3 G947R mutant mice have severe motor impairments, inducible hemiplegia and dystonic-like behaviors • Atp1a3 G947R mutant mice exhibit a prominent seizure phenotype with EEG abnormalities resembling co-morbid epilepsy in AHC
No takes yet. Share an insight, caveat, or question.
Hawkins et al. (2024) studied Alternating hemiplegia of childhood (AHC). Heterozygous Atp1a3-G947R mutation vs. Wildtype (WT) littermates was evaluated on Neurological phenotypes including motor dysfunction, seizures, and EEG abnormalities. Heterozygous Atp1a3-G947R mutant mice exhibit severe motor impairments, inducible hemiplegia, dystonia, and a prominent seizure phenotype resembling co-morbid epilepsy in AHC.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: